Is MCD stock today a buy for Singapore investors?

It depends on risk tolerance. The trend is positive and fundamentals are strong, but valuation is full at a 27.4 PE and technicals read overbought. Analyst views skew Buy/Hold, while one model flags caution. Consider phasing entries, watching April results, and managing USD exposure.

How could the GLP-1 menu affect McDonald’s revenue?

If protein-rich items and smaller portions keep GLP-1 users engaged, visits and average checks could hold up. The risk is trading down or skipping orders. Success would support traffic, beverage attach rates, and mix. Investors should watch test feedback, reorders, and any broader rollout timing.

What are the key risks to MCD stock today?

Key risks include slower consumer spending, menu test underperformance, pricing pushback, and competitive responses. Valuation risk is present with a premium multiple. Currency matters for SG investors. Watch margins, same-store sales, and commentary on GLP-1 adoption and beverage trends in the next update.

When is McDonald’s next earnings report and what should I watch?

McDonald’s is scheduled for 30 April 2026 at 21:00 UTC. Track global comparable sales, traffic versus average check, digital ordering, delivery mix, and guidance. Listen for details on GLP-1 menu tests, beverage attach rates, and any planned rollouts or pricing moves for the rest of the year.

Global Market Insights

MCD Stock Today, February 18: GLP-1 Menu Tests Aim to Defend Traffic

ByDanny Kontos February 18, 2026February 18, 2026

MCD stock today is in focus as McDonald’s pilots a GLP-1 menu featuring protein-rich items and smaller portions to serve Ozempic and Wegovy users. We look at MCD through Singapore’s lens: demand risks, pricing power, and near-term catalysts. Recent quotes show shares near $327.145 with a strong uptrend year to date. If the tests defend traffic and average checks, sentiment could improve. We outline what matters for results, the chart view, and actions SG investors can consider now.